Atlas Trials

Evaluating Possible Improvement in Tinnitus Severity After 28 Days Dosing of the Study Drug AUT00063 Compared to Placebo

Clinical trial NCT02315508 · COMPLETED

Trial details

NCT number
NCT02315508
Sponsor
Autifony Therapeutics Limited
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Tinnitus, Subjective
Start date
2014-10-01
Primary completion
2015-12-01
Enrollment
91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.